Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. In the UK, our medicines fill over 100 million prescriptions and reach nearly 6 million patients every year. With licences for over 600 medicines in the UK, we cover the major therapeutic areas. We aim to ensure medicines better serve the needs of patients and to create a sustainable market for generic companies to continue to invest in the UK.